IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy

By Vaz-Santiago J   Lulé J   Rohrlich P   Kravtzoff R   Le Roy E   Davignon J-L   Betbeder D   Davrinche C  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 11-19

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immunotherapy for CMV infection

By Einsele H  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 435-436

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma

By Gottlieb Dj   Micklethwaite K.   Bradstock Kf   Li Y-Ch  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 133-143

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease

By Hobeika Ac   Osada T.   Serra D.   Peplinski S.   Hanson K.   Tanaka Y.   Niedzwiecki D.   Chao N.   Rizzieri D.   Lyerly Hk   Clay T.   Morse Ma  

Cytotherapy, Vol. 10, Iss. 3, 2008-01 ,pp. : 289-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Real-time monitoring of immune responses

By Wieder ED  

Cytotherapy, Vol. 4, Iss. 4, 2002-07 ,pp. : 347-352

Ashgate Publishing Ltd

Access to resources Recommend Favorite